Hiv Obesity clinical trials

Explore recruiting hiv obesity clinical trials.

Recruiting hiv obesity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hiv Obesity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight loss in people living with HIV and obesity (SWIFT Study)

Ireland, Denmark, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Hiv Obesity trials by city

Hiv Obesity in Toronto Hiv Obesity in Vancouver Hiv Obesity in Montreal Hiv Obesity in Calgary Hiv Obesity in Edmonton Hiv Obesity in Ottawa Hiv Obesity in Winnipeg Hiv Obesity in Quebec City Hiv Obesity in Hamilton Hiv Obesity in Kitchener Hiv Obesity in London Hiv Obesity in Halifax Hiv Obesity in New York Hiv Obesity in Los Angeles Hiv Obesity in Chicago Hiv Obesity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease